Benitec Biopharma Inc. Quarterly Return On Equity in % from Q2 2020 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Benitec Biopharma Inc. quarterly/annual Return On Equity history and growth rate from Q2 2020 to Q3 2024.
  • Benitec Biopharma Inc. Return On Equity for the quarter ending September 30, 2024 was -60.3 %, a 73.3% increase year-over-year.
  • Benitec Biopharma Inc. annual Return On Equity for 2024 was -90.1 %, a 67.1% increase from 2023.
  • Benitec Biopharma Inc. annual Return On Equity for 2023 was -274 %, a 38.3% decline from 2022.
  • Benitec Biopharma Inc. annual Return On Equity for 2022 was -198 %, a 90.4% decline from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -60.3 +165 +73.3% Jul 1, 2024 Sep 30, 2024
Q2 2024 -90.1 +184 +67.1% Apr 1, 2024 Jun 30, 2024
Q1 2024 -175 +80.6 +31.5% Jan 1, 2024 Mar 31, 2024
Q4 2023 -204 +17.3 +7.81% Oct 1, 2023 Dec 31, 2023
Q3 2023 -226 -21.9 -10.7% Jul 1, 2023 Sep 30, 2023
Q2 2023 -274 -76 -38.3% Apr 1, 2023 Jun 30, 2023
Q1 2023 -256 -129 -101% Jan 1, 2023 Mar 31, 2023
Q4 2022 -222 -97.5 -78.5% Oct 1, 2022 Dec 31, 2022
Q3 2022 -204 -97.5 -91.8% Jul 1, 2022 Sep 30, 2022
Q2 2022 -198 -94.2 -90.4% Apr 1, 2022 Jun 30, 2022
Q1 2022 -127 -9.62 -8.17% Jan 1, 2022 Mar 31, 2022
Q4 2021 -124 -26.2 -26.8% Oct 1, 2021 Dec 31, 2021
Q3 2021 -106 -19.8 -22.9% Jul 1, 2021 Sep 30, 2021
Q2 2021 -104 -43.8 -72.5% Apr 1, 2021 Jun 30, 2021
Q1 2021 -118 Jan 1, 2021 Mar 31, 2021
Q4 2020 -98 Oct 1, 2020 Dec 31, 2020
Q3 2020 -86.4 Jul 1, 2020 Sep 30, 2020
Q2 2020 -60.4 Apr 1, 2020 Jun 30, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.